scholarly journals Patterns and determinants of prescribed drug use among pregnant women in Adigrat general hospital, northern Ethiopia: a cross-sectional study

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Niguse Meles Alema ◽  
Getachew Semagn ◽  
Shetey Melesse ◽  
Ephrem Mebrahtu Araya ◽  
Hagazi Gebremedhin ◽  
...  

Abstract Background A vigilant prescription of drugs during pregnancy can potentially safeguard the growing fetus from the deleterious effect of the drug while attempting to manage the mother’s health problems. There is a paucity of information about the drug utilization pattern in the area of investigation. Hence, this study was implemented to investigate the pattern of drug utilization and its associated factors among pregnant women in Adigrat general hospital, Northern Ethiopia. Methods An institution-based cross-sectional study was conducted among randomly selected 314 pregnant women who attended obstetrics-gynecology and antenatal care units of the hospital. Relevant data were retrieved from the pregnant women’s medical records and registration logbook. The drugs prescribed were categorized based on the United States Food and Drug Administration (US-FDA) fetal harm classification system. Data analysis was done using SPSS version 20 statistical software. Multivariate logistic regression was employed to analyze the association of the explanatory variables with the medication use, and p < 0.05 was declared statistically significant. Results The overall prescribed drug use in this study was found to be 87.7%. A considerable percentage of the study participants (41.4%) were prescribed with supplemental drugs (iron folate being the most prescribed drug) followed by antibiotics (23.4%) and analgesics (9.2%). According to the US-FDA drug’s risk classification, 42.5, 37, 13, and 7% of the drugs prescribed were from categories A, B, C, and D or X respectively. Prescribed drug use was more likely among pregnant women who completed primary [AOR = 5.34, 95% CI (1.53–18.6)] and secondary education [AOR = 4.1, 95% CI (1.16–14)], who had a history of chronic illness [AOR = 7.9, 95% CI (3.14–19.94)] and among multigravida women [AOR = 2.9, 95% CI (1.57 5.45)]. Conclusions The finding of this study revealed that a substantial proportion of pregnant women received drugs with potential harm to the mother and fetus. Reasonably, notifying health practitioners to rely on up-to-date treatment guidelines strictly is highly demanded. Moreover, counseling and educating pregnant women on the safe and appropriate use of medications during pregnancy are crucial to mitigate the burden that the mother and the growing fetus could face.

2020 ◽  
Author(s):  
Ermias Alemayehu ◽  
Alemu Gedefie ◽  
Aderaw Adamu ◽  
Jemal Mohammed ◽  
Brhanu Kassanew ◽  
...  

Abstract Background: Parasitic infections are known causes of morbidity among HIV infected patients with low CD4+ counts who are on antiretroviral therapy; mainly as a result of immune suppression. Thus, this study aimed to assess the extent of intestinal parasitic infection and its related risk factors among HIV infected patients attending ART clinic of Debretabor General Hospital, Northern Ethiopia.Patients and methods: A health facility based cross sectional study was conducted on a total of 383 HIV infected patients attending ART clinic of Debretabor General Hospital, Northern Ethiopia from December 2018 to March 2019. An interview based structured questionnaire were used to gather socio-demographic and risk factor data. About 5 grams of fresh stool specimen and 4 ml of venous blood sample were collected, then transported and tested in accordance with the laboratory standard operating procedures. The obtained data was entered into SPSS version 22.0; and analyzed. P-value <0.05 with 95% confidence interval was considered statistically significant.Result: The overall prevalence of intestinal parasites was 25.3%; with 18% and 23.8% by direct wet mount and formol-ether concentration technique respectively. 8 (2.1%) patients were infected by multiple parasites in concentration technique. Ascaris lumbricoides, 23(25.3%) was the most frequently identified parasite. Parasitic infection was significantly higher among illiterates (P=0.011); patients with a CD4 count of <200 cells/mm3 (P<0.001) and among patients who did not have latrine (P=0.049) than their counter parts.Conclusion: Relatively higher prevalence of intestinal parasitic infection was found among HIV/AIDS patients. The distribution of intestinal parasites is greatly affected by illiteracy, reduced CD4+ counts and absence of toilet. Thus, HIV/AIDS patients with low CD4+ counts should be diagnosed consistently for intestinal parasites and routine stool examination and awareness creation should be advocated to be included as an essential component of the ART monitoring strategy for improved patient care.


BMJ Open ◽  
2018 ◽  
Vol 8 (2) ◽  
pp. e020248 ◽  
Author(s):  
Victoria H Coleman-Cowger ◽  
Emmanuel A Oga ◽  
Erica N Peters ◽  
Kathleen Trocin ◽  
Bartosz Koszowski ◽  
...  

IntroductionPrescription-drug use in the USA has increased by more than 60% in the last three decades. Prevalence of prescription-drug use among pregnant women is currently estimated around 50%. Prevalence of illicit drug use in the USA is 14.6% among pregnant adolescents, 8.6% among pregnant young adults and 3.2% among pregnant adults. The first step in identifying problematic drug use during pregnancy is screening; however, no specific substance-use screener has been universally recommended for use with pregnant women to identify illicit or prescription-drug use. This study compares and validates three existing substance-use screeners for pregnancy—4 P’s Plus, National Institute on Drug Abuse (NIDA) Quick Screen/Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) and the Substance Use Risk Profile-Pregnancy (SURP-P) scale.Methods and analysisThis is a cross-sectional study designed to evaluate the sensitivity, specificity and usability of existing substance-use screeners. Recruitment occurs at two obstetrics clinics in Baltimore, Maryland, USA. We are recruiting 500 participants to complete a demographic questionnaire, NIDA Quick Screen/ASSIST, 4 P’s Plus and SURP-P (ordered randomly) during their regularly scheduled prenatal appointment, then again 1 week later by telephone. Participants consent to multidrug urine testing, hair drug testing and allowing access to prescription drug and birth outcome data from electronic medical records. For each screener, reliability and validity will be assessed. Test–retest reliability analysis will be conducted by examining the results of repeated screener administrations within 1 week of original screener administrations for consistency via correlation analysis. Furthermore, we will assess if there are differences in the validity of each screener by age, race and trimester.Ethics and disseminationThis study is approved by the Institutional Review Board of the University of Maryland (HP-00072042), Baltimore, and Battelle Memorial Institute (0619–100106433). All participants are required to give their informed consent prior to any study procedure.


Sign in / Sign up

Export Citation Format

Share Document